Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 673

    1.

    Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.

    Gupta K, Hooton TM, Stamm WE.

    Ann Intern Med. 2001 Jul 3;135(1):41-50. Review.PMID: 11434731 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Addressing antibiotic resistance.

    Gupta K.

    Dis Mon. 2003 Feb;49(2):99-110. Review.PMID: 12601340 [PubMed - indexed for MEDLINE]Related articles

    3.

    The current management strategies for community-acquired urinary tract infection.

    Hooton TM.

    Infect Dis Clin North Am. 2003 Jun;17(2):303-32. Review.PMID: 12848472 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance.

    Miller LG, Tang AW.

    Mayo Clin Proc. 2004 Aug;79(8):1048-53; quiz 1053-4. Review.PMID: 15301333 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI.

    Gupta K, Stamm WE.

    Int J Antimicrob Agents. 2002 Jun;19(6):554-6. Review.PMID: 12135847 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Urinary tract infections and antibiotic resistance]

    Malinverni R.

    Ther Umsch. 2002 Jan;59(1):31-5. German. PMID: 11851044 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.

    Garrison J, Hooton TM.

    Expert Opin Pharmacother. 2001 Aug;2(8):1227-37. Review.PMID: 11584990 [PubMed - indexed for MEDLINE]Related articles

    8.

    Addressing antibiotic resistance.

    Gupta K.

    Am J Med. 2002 Jul 8;113 Suppl 1A:29S-34S. Review.PMID: 12113869 [PubMed - indexed for MEDLINE]Related articles

    9.

    Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.

    Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W; Israeli Urinary Tract Infection Group.

    Clin Infect Dis. 2002 May 1;34(9):1165-9. Epub 2002 Apr 4.PMID: 11941541 [PubMed - indexed for MEDLINE]Related articles

    10.

    Urinary tract infection: traditional pharmacologic therapies.

    Nicolle LE.

    Dis Mon. 2003 Feb;49(2):111-28. Review.PMID: 12601341 [PubMed - indexed for MEDLINE]Related articles

    11.

    Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.

    Hooton TM.

    Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:65-72. Review.PMID: 14527774 [PubMed - indexed for MEDLINE]Related articles

    12.

    Urinary tract infection: traditional pharmacologic therapies.

    Nicolle LE.

    Am J Med. 2002 Jul 8;113 Suppl 1A:35S-44S. Review.PMID: 12113870 [PubMed - indexed for MEDLINE]Related articles

    13.

    Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.

    Colgan R, Johnson JR, Kuskowski M, Gupta K.

    Antimicrob Agents Chemother. 2008 Mar;52(3):846-51. Epub 2007 Dec 17.PMID: 18086847 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Assessing adherence to evidence-based guidelines for the diagnosis and management of uncomplicated urinary tract infection.

    Grover ML, Bracamonte JD, Kanodia AK, Bryan MJ, Donahue SP, Warner AM, Edwards FD, Weaver AL.

    Mayo Clin Proc. 2007 Feb;82(2):181-5.PMID: 17290725 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.

    Gomolin IH, Siami PF, Reuning-Scherer J, Haverstock DC, Heyd A; Oral Suspension Study Group.

    J Am Geriatr Soc. 2001 Dec;49(12):1606-13.PMID: 11843992 [PubMed - indexed for MEDLINE]Related articles

    16.

    Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.

    Wright SW, Wrenn KD, Haynes ML.

    J Gen Intern Med. 1999 Oct;14(10):606-9.PMID: 10571705 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.

    Talan DA, Naber KG, Palou J, Elkharrat D.

    Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S54-66. Review.PMID: 15037329 [PubMed - indexed for MEDLINE]Related articles

    18.

    Trimethoprim/sulfamethoxazole resistance in urinary tract infections.

    Guneysel O, Onur O, Erdede M, Denizbasi A.

    J Emerg Med. 2009 May;36(4):338-41. Epub 2008 Mar 6.PMID: 18325714 [PubMed - indexed for MEDLINE]Related articles

    19.

    Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.

    Arslan H, Azap OK, Ergönül O, Timurkaynak F; Urinary Tract Infection Study Group.

    J Antimicrob Chemother. 2005 Nov;56(5):914-8. Epub 2005 Sep 20.PMID: 16174685 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.

    Le TP, Miller LG.

    Clin Infect Dis. 2001 Sep 1;33(5):615-21. Epub 2001 Jul 30.PMID: 11486284 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data